Search

Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’ are now open for applications. The bi-annual awards reflect the long-term commitment to promoting the health and well-being of farm animals.

Positive results Diabetic Macular Ischemia treatment

HORNBILL Phase I/II study shows positive results for potentially first ever Diabetic Macular Ischemia treatment

License deal with A*STAR to develop cancer antibodies

clinical_collaboration_with_Mirati

Boehringer Ingelheim and Mirati are teaming up in a clinical collaboration to evaluate the combination of the SOS1::pan-KRAS and the selective G12C inhibitor.

Aservo EquiHaler wins Pharmapack Award 2021

Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards

AUROBAC's Strategy & Pipeline Against Severe Infections & Resistance

AUROBAC THERAPEUTICS presents strategy and growing pipeline to tackle severe infections and antimicrobial resistance

EURORDIS Award

EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020

Partnering with Lifebit to detect global disease outbreaks

Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

EFPIA disclosure

Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations.

SIRPα Cancer Immunology Research

Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.

Boehringer Ingelheim invests in precision cancer treatments

Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies

Digital innovation: Our digital pipeline is only growing

BRASS, a software advancing patient safety and developed fully in-house, has been sold. This is proof: our digital innovations are in demand.

Generalized pustular psoriasis (GPP): a chronic inflammatory disease

Learn more about this chronic inflammatory disease associated with skin and systemic symptoms

New vaccine against Bovine Respiratory Disease

Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.

Survey with Ipsos to gain insights human-animal bond

Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.

Approval for Aservo EquiHaler equine asthma therapy

Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy

Mental health: a $1 trillion burden demanding policy action

Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.

Shared science for the best cat diabetes management

Diabetes mellitus is a common endocrine disease with increasing prevalence in dogs and cats. Learn how science's made management easier.

Making-more-health-together-2021

1,200 participants from around the world join virtual convention on November 11-12

Innovating for our business

We drive innovation across our complex business landscape at Boehringer Ingelheim. Technology is an integral part of our core business processes and we focus on advanced technologies.

EASi-KIDNEY™ Phase III trial for people with CKD

Boehringer Ingelheim's Sandy Sommer on how treatment innovations in CKD can also improve care for connected conditions, including heart failure.

Translating Human Pharma Science into Animal Health Innovation

Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health

collaboration criving innovation

In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.

Facts about the INPULSIS™ trials

Boehringer Ingelheim strong growth pipeline acceleration 2023

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers